KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) EBT Margin (2016 - 2026)

Medtronic's EBT Margin history spans 13 years, with the latest figure at 15.57% for Q1 2026.

  • For Q1 2026, EBT Margin fell 300.0% year-over-year to 15.57%; the TTM value through Jan 2026 reached 15.68%, down 5.0%, while the annual FY2025 figure was 16.78%, 184.0% up from the prior year.
  • EBT Margin for Q1 2026 was 15.57% at Medtronic, down from 17.81% in the prior quarter.
  • Across five years, EBT Margin topped out at 20.47% in Q1 2022 and bottomed at 9.97% in Q2 2024.
  • The 5-year median for EBT Margin is 17.79% (2023), against an average of 16.75%.
  • The largest annual shift saw EBT Margin skyrocketed 478bps in 2022 before it tumbled -818bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 18.39% in 2022, then fell by -11bps to 16.45% in 2023, then increased by 13bps to 18.55% in 2024, then dropped by -4bps to 17.81% in 2025, then dropped by -13bps to 15.57% in 2026.
  • Per Business Quant, the three most recent readings for MDT's EBT Margin are 15.57% (Q1 2026), 17.81% (Q4 2025), and 15.18% (Q3 2025).